ArticleFrontiers in oncology2023

Association of early immune-related adverse events with treatment efficacy of neoadjuvant Toripalimab in resectable advanced non-small cell lung cancer.

Ye Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.